课题基金 / 基金详情

AIMED: participatory adaptation of an intervention to reduce rates of early hospital discharge among people living with HIV who use substances

AIMED: participatory adaptation of an intervention to reduce rates of early hospital discharge among people living with HIV who use substances
目标:参与性地调整干预措施,以降低使用药物的艾滋病毒感染者的早期出院率
批准号:
332549
负责人:
Strike Carol J
金额:
$2.34万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-04-01 至 2016-04-01

项目摘要

项目成果

Strike Carol J的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objective of our community based research project is to adapt AIMED, a recently advanced intervention, for use with substance using PHAs to reduce instances of leaving AMA and improve their hospital-based care(ref). AIMED recognizes that most AMA dis
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
How the COVID 19 pandemic and overdose epidemics are changing addictions medicine: stakeholder perspectives
  • 批准号:
    460372
  • 项目类别:
    Operating Grants
  • 资助金额:
    $23.45万
  • 财政年份:
    2021
  • 负责人:
    Strike Carol J
  • 依托单位:
Looking back to look ahead - the CAHR Strategic Plan 2019-2024
  • 批准号:
    391864
  • 项目类别:
    Miscellaneous Programs
  • 资助金额:
    $1.46万
  • 财政年份:
    2018
  • 负责人:
    Strike Carol J
  • 依托单位:
HIV prevention, supervised injection services, and collaborative relationships with police: Development of a training program
  • 批准号:
    353112
  • 项目类别:
    Miscellaneous Programs
  • 资助金额:
    $0.72万
  • 财政年份:
    2016
  • 负责人:
    Strike Carol J
  • 依托单位:
Day Health Programs for complex care delivery: Using implementation science and participatory methods to evaluate success and ethical care delivery for people living with HIV
  • 批准号:
    342840
  • 项目类别:
    Operating Grants
  • 资助金额:
    $30.36万
  • 财政年份:
    2015
  • 负责人:
    Strike Carol J
  • 依托单位:
国内基金
海外基金
人类免疫缺陷病毒(HIV)总核酸检测试剂盒
HIV相关肺癌免疫微环境中关键免疫细胞亚群的功能特征与调控机制研究
基于深度测序与SNV 芯片的HIV重复感染与毒株重组机制研究
  • 批准号:
    2026JJ81281
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    徐艳
  • 依托单位:
PGT123中和抗体修饰的工程化载肽囊泡疫苗通过诱导CD4+ T细胞极化在抗HIV感染中的应用和机制研究